Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Archives of Neurology|August 16, 2006
Altered vascular phenotype in autism: correlation with oxidative stressYuemang Yao, William J Walsh, Woody R McGinnis, et al.
Prostaglandins & Other Lipid Mediators|November 24, 2005
12/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathwayLei Zhao, Domenico Praticò, Daniel J Rader, et al.
Circulation|November 4, 2005
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient miceMyan Tang, Tillmann Cyrus, Yuemang Yao, et al.
Aging Cell|July 19, 2013
The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivoPhillip F Giannopoulos, Yash B Joshi, Jin Chu, et al.
Aging Cell|November 26, 2019
Extra virgin olive oil improves synaptic activity, short-term plasticity, memory, and neuropathology in a tauopathy modelElisabetta Lauretti, Miroslav Nenov, Ozlem Dincer, et al.
Neurobiology of Aging|December 17, 2013
Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenaseYash B Joshi, Phillip F Giannopoulos, Jin Chu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 1, 2022
Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndromeMary Elizabeth Curtis, Tiffany Smith, Benjamin E Blass, et al.
Journal of Pediatric Hematology/Oncology|September 19, 2008
Pseudohypoparathyroidism Ia with Evans syndromePiero Pavone, Andrea Domenico Praticò, Danilo Castellano-Chiodo, et al.
Circulation|February 5, 2003
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesionsTillmann Cyrus, Yuemang Yao, Joshua Rokach, et al.
European Journal of Pharmacology|February 20, 2007
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
Pageof 20